Melatonin Works — But It Doesn’t Work Alone

Roughly 1 in 5 American children now take a dietary supplement, and melatonin sits near the top of that list, sold as colorful gummies in the same pharmacy aisle as children’s vitamins. A 2025 review from Cohen Children’s Medical Center at Northwell Health pulls together what pediatricians actually know about these products, including melatonin’s real benefits, its limits, and a purity problem most parents have never heard about.

Melatonin Works — But It Doesn’t Work Alone

Melatonin is a hormone the pineal gland produces naturally in response to darkness; it signals to the body’s circadian system that night has arrived. Supplemental melatonin borrows this mechanism, which is why it tends to help most with timing problems, such as delayed sleep onset, rather than with staying asleep.

In their 2025 review in Current Opinion in Pediatrics, Dr. Matthew Lowance and colleagues at Northwell Health found that melatonin, alongside magnesium and fish oil, can reduce symptoms of hyperactivity, sleep disturbance, and conduct problems in children, but only in combination with other interventions. Their conclusion is blunt: none of these supplements rival the efficacy of first-line treatment plans. For pediatric sleep problems, that first line is behavioral, not pharmaceutical. Related reading on how evening habits shape children’s sleep can be found in our coverage of the screen time, sleep, and mental health link.

Purity of US-Sold Melatonin Is Very Poor

Here is the finding parents should weigh most heavily. Writing in Current Pain and Headache Reports, Dr. Stewart Tepper and Katherine Tepper of the New England Institute for Neurology and Headache note that melatonin has very low certainty of evidence even for its best-studied use, migraine prevention, and that “purity of US sold melatonin is very poor.”

The reason is regulatory. Nutraceuticals, melatonin included, fall outside the FDA’s drug-approval framework, so manufacturers do not have to prove their products contain what the label claims. Because melatonin content can deviate substantially from the stated dose, a child given “1 mg” from one bottle may effectively receive several times that. This variability matters most at the small doses pediatricians typically recommend, where a manufacturing error is proportionally enormous. For adults, timing and dose alignment matter too; see how a 6 PM melatonin dose aligns with the sleep cycle.

Dosing: Start Low, Watch for Overuse

The Northwell review raises a second red flag: overuse of supplements, including hormonal ones like melatonin, can lead to toxicity and adverse effects. Mechanistically, this makes sense. Melatonin receptors sit in the brain’s circadian clock, but the hormone also has receptors elsewhere, and supraphysiologic doses can produce daytime grogginess, headaches, and, in young children, effects on hormonal signaling that are not yet fully characterized. The same authors emphasize that dosing, safety, and efficacy of dietary supplements in children remain largely unknown territory.

Practical translation: if melatonin is used at all, pediatric guidance generally favors doses at the low end, often 0.5 to 1 mg taken 30 to 60 minutes before bed, with the dose only adjusted under a clinician’s direction. The same caution applies to magnesium and fish oil, the other two supplements with some pediatric evidence. Note that fish oil’s developmental claims connect to broader nutrition science, covered in our article on omega-3 DHA and child brain development.

What This Means for Parents at the Pharmacy Aisle

The Northwell team titled their review “Aisles of health?” with a question mark, and their summary answer is restrained. Vitamin and mineral supplements help children with documented deficiencies or restrictive diets; for healthy children eating a balanced diet, evidence of added benefit is minimal. Applying that to sleep:

• Rule out causes first. Anxiety, ADHD, screen exposure, and inconsistent schedules cause most childhood insomnia; melatonin masks rather than fixes these.
• Try behavioral methods first. Consistent bedtimes, dim light in the evening, and no screens before bed remain the evidence-backed foundation.
• Choose third-party tested products. Look for USP or NSF certification, since FDA approval does not apply.
• Treat melatonin as a short-term aid, used at the lowest effective dose and revisited with your pediatrician, not a nightly lifelong habit.

One honest limitation runs through the research: pediatric melatonin trials are small, short, and inconsistent in dosing, which is why review authors describe evidence certainty as low even when they see a benefit.

Melatonin is neither a menace nor a miracle. Current evidence supports it as a modest, timing-focused helper for some children with sleep difficulties, layered onto behavioral strategies and medical evaluation. Its biggest dangers are overconfidence and an unregulated supply chain. Used sparingly, at low doses, with a pediatrician’s input, it has a place; used casually as a gummy bedtime vitamin, it deserves more skepticism than the pharmacy shelf suggests.

Frequently Asked Questions

What is a safe starting dose of melatonin for children?

Pediatric practice generally starts at 0.5 to 1 mg, given 30 to 60 minutes before bedtime, with any increase guided by a clinician; the 2025 Northwell review stresses that dosing and safety data in children remain limited.

Is melatonin FDA-approved for kids?

No. Melatonin is sold as a dietary supplement, which the FDA does not regulate like a drug, meaning purity and dose are not verified before sale.

Why do researchers say US melatonin purity is poor?

Because supplements skip FDA drug approval, independent analyses have found actual melatonin content often deviates from the label, sometimes by large multiples, making precise pediatric dosing unreliable.

Can melatonin treat ADHD or behavioral problems directly?

The evidence shows melatonin may reduce sleep disturbance and hyperactivity symptoms only in combination with other treatments, and it does not approach the efficacy of first-line ADHD or behavioral interventions.

Sources:
https://pubmed.ncbi.nlm.nih.gov/40439702/
https://pubmed.ncbi.nlm.nih.gov/39853578/
https://pubmed.ncbi.nlm.nih.gov/39277823/
https://pubmed.ncbi.nlm.nih.gov/38025149/
https://pubmed.ncbi.nlm.nih.gov/35723382/